1. Home
  2. RVPH vs IZEA Comparison

RVPH vs IZEA Comparison

Compare RVPH & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • IZEA
  • Stock Information
  • Founded
  • RVPH 2006
  • IZEA 2006
  • Country
  • RVPH United States
  • IZEA United States
  • Employees
  • RVPH N/A
  • IZEA N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • RVPH Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • RVPH 32.8M
  • IZEA 44.6M
  • IPO Year
  • RVPH N/A
  • IZEA N/A
  • Fundamental
  • Price
  • RVPH $0.38
  • IZEA $3.31
  • Analyst Decision
  • RVPH Strong Buy
  • IZEA
  • Analyst Count
  • RVPH 5
  • IZEA 0
  • Target Price
  • RVPH $9.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • RVPH 3.8M
  • IZEA 52.8K
  • Earning Date
  • RVPH 08-13-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • RVPH N/A
  • IZEA N/A
  • EPS Growth
  • RVPH N/A
  • IZEA N/A
  • EPS
  • RVPH N/A
  • IZEA N/A
  • Revenue
  • RVPH N/A
  • IZEA $36,896,490.00
  • Revenue This Year
  • RVPH N/A
  • IZEA $22.24
  • Revenue Next Year
  • RVPH N/A
  • IZEA N/A
  • P/E Ratio
  • RVPH N/A
  • IZEA N/A
  • Revenue Growth
  • RVPH N/A
  • IZEA 7.17
  • 52 Week Low
  • RVPH $0.30
  • IZEA $1.68
  • 52 Week High
  • RVPH $4.28
  • IZEA $3.49
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 34.83
  • IZEA 74.88
  • Support Level
  • RVPH $0.38
  • IZEA $2.55
  • Resistance Level
  • RVPH $0.45
  • IZEA $3.15
  • Average True Range (ATR)
  • RVPH 0.05
  • IZEA 0.17
  • MACD
  • RVPH 0.01
  • IZEA 0.08
  • Stochastic Oscillator
  • RVPH 52.37
  • IZEA 82.65

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: